Find information on thousands of medical conditions and prescription drugs.

Anakinra

Anakinra is an IL-1 receptor antagonist, often used as a disease-modulating anti-rheumatoid drug. This drug is known by the tradename "Kineret" and is produced by the pharmaceutical company Amgen.

A

Acetylcholine chloride

Acetyldigitoxin

Alvircept sudotox

Aminocaproic acid

Aminoglutethimide

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Anakinra gets FDA nod for rheumatoid arthritis. (Interleukin-1 Blocker). : An article from: Internal Medicine News $5.95			Rare disorder responds to Anakinra treatment.(Dermatologic Therapy)(Muckle-Wells syndrome) : An article from: Skin & Allergy News $5.95

		Anakinra Gets FDA's Okay For Rheumatoid Arthritis. (Interleukin-1 Blocker).(Brief Article) : An article from: Family Practice News $5.95


	Anakinra to treat patients with neonatal onset multisystem inflammatory disease This study is currently recruiting patients. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) This study ... From Journal of Drugs in Dermatology, 5/1/04

	Using anakinra for adult rheumatoid arthritis Drug News Joint destruction begins as early as 3 to 6 months after disease onset. In fact, joint destruction may progress despite clinical signs of improvement ... From Nurse Practitioner, 4/1/02 by Kupecz, Deborah

	New uses for old drugs: Novel therapeutic options Byline: Ujala. Verma, R. Sharma, P. Gupta, B. Kapoor, G. Bano, V. Sawhney Introducing a new drug to the market now costs an average of US$ 897 million ... From Indian Journal of Pharmacology, 9/1/05 by Ujala Verma

	Rheumatoid arthritis drugs The autoimmune disorder rheumatoid arthritis occurs in about 1%-2% of the population. The disease is more prevalent in women than men by about a 3:1 ... From OB/GYN News, 4/15/05 by Gerald G. Briggs

	New molecular entity: Vesicare®, Yamanouchi/ GlaxoSmithKline Solifenacin: once-daily therapy approved for overactive bladder Solifenacin was approved for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Dosage. The recommended dose of solifenacin is 5 From Geriatrics, 1/1/05

	Immunomodulators Several immunologic agents--adalimumab, anakinra, etanercept, three classes of interferons, and thalidomide--are classified in the general category of immunomodulators. They are used for various ap From OB/GYN News, 4/15/04 by Gerald G. Briggs

	Weekly profile AMGEN INC. Symbol: AMGN Exchange: NASDAQ Close: 57.58 1-WK % Chg: -0.7% Business Overview Amgen Inc., incorporated in 1980, is a global biotechnology ... From Los Angeles Business Journal, 10/11/04

	Drug makers sponsor rheumatology Web site - Pharmacy Briefs - Brief Article THOUSAND OAKS, Calif. -- Amgen and three other drug makers are sponsoring RheumatologyWeb, part of the Vertibrae group of online medical education sites. From Drug Store News, 6/17/02

Home

Contact

Resources

ebay